Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7) Peptid
-
- Target Alle CHRNA7 Produkte
- CHRNA7 (Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7))
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Verwendungszweck
- Nicotinic Acetylcholine Receptor α7/CHRNA7 (extracellular) Negative Control Antigen
- Sequenz
- (C)KELVKNYNPL ER, correspond ing to amino acid residues 31-42 of rat nAChRα7 (Accession Q05941).
- Produktmerkmale
- Synthetic peptide, A Blocking peptide for Anti-Nicotinic Acetylcholine Receptor α7 (CHRNA7) (extracellular) Antibody (ABIN7043067, ABIN7044631 and ABIN7044632)) and Anti-Nicotinic Acetylcholine Receptor α7 (CHRNA7) (extracellular)-ATTO Fluor-633 Antibody (#ABIN7043068). Intended to be used as a negative control.
- Reinheit
- >70 %
-
-
- Applikationshinweise
- Antigen Preadsorption Control: 1 μg peptide per 1 μg antibody.
- Kommentare
-
Confirmed by amino acid analysis and mass spectrometry.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- 100 μL double distilled water (DDW).
- Lagerung
- RT,-20 °C
- Informationen zur Lagerung
- Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
-
-